Literature DB >> 25137548

A Novel SHOC2 Variant in Rasopathy.

Vickie Hannig1, Myoungkun Jeoung, Eun Ryoung Jang, John A Phillips, Emilia Galperin.   

Abstract

Rasopathies are a group of genetic disorders caused by germline mutations in multiple genes of the Extracellular signal-Regulated Kinases 1 and 2 (ERK1/2) pathway. The only previously identified missense mutation in SHOC2, a scaffold protein of the ERK1/2 pathway, led to Noonan-like syndrome with loose anagen hair. Here, we report a novel mutation in SHOC2(c.519G>A; p.M173I) that leads to a Rasopathy with clinical features partially overlapping those occurring in Noonan and cardiofaciocutaneous syndromes. Studies to clarify the significance of this SHOC2 variant revealed that the mutant protein has impaired capacity to interact with protein phosphatase 1c (PP1c), leading to insufficient activation of RAF-1 kinase. This SHOC2 variant thus is unable to fully rescue ERK1/2 activity in cells depleted of endogenous SHOC2. We conclude that SHOC2 mutations can cause a spectrum of Rasopathy phenotypes in heterozygous individuals. Importantly, our work suggests that individuals with mild Rasopathy symptoms may be underdiagnosed.
© 2014 WILEY PERIODICALS, INC.

Entities:  

Keywords:  ERK1/2 pathway; Rasopathies; SHOC2; signaling

Mesh:

Substances:

Year:  2014        PMID: 25137548      PMCID: PMC4213265          DOI: 10.1002/humu.22634

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  19 in total

1.  A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.

Authors:  Pablo Rodriguez-Viciana; Juan Oses-Prieto; Alma Burlingame; Mike Fried; Frank McCormick
Journal:  Mol Cell       Date:  2006-04-21       Impact factor: 17.970

2.  PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects.

Authors:  Maria I Kontaridis; Kenneth D Swanson; Frank S David; David Barford; Benjamin G Neel
Journal:  J Biol Chem       Date:  2005-12-23       Impact factor: 5.157

3.  Comprehensive massive parallel DNA sequencing strategy for the genetic diagnosis of the neuro-cardio-facio-cutaneous syndromes.

Authors:  Ana Justino; Patrícia Dias; Maria João Pina; Sónia Sousa; Luís Cirnes; Ana Berta Sousa; José Carlos Machado; José Luis Costa
Journal:  Eur J Hum Genet       Date:  2014-06-04       Impact factor: 4.246

4.  Towards a comprehensive analysis of the protein phosphatase 1 interactome in Drosophila.

Authors:  Daimark Bennett; Ekaterina Lyulcheva; Luke Alphey; Gillian Hawcroft
Journal:  J Mol Biol       Date:  2006-09-07       Impact factor: 5.469

5.  The face of Noonan syndrome: Does phenotype predict genotype.

Authors:  Judith E Allanson; Axel Bohring; Helmuth-Guenther Dörr; Andreas Dufke; Gabrielle Gillessen-Kaesbach; Denise Horn; Rainer König; Christian P Kratz; Kerstin Kutsche; Silke Pauli; Salmo Raskin; Anita Rauch; Anne Turner; Dagmar Wieczorek; Martin Zenker
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

6.  Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome.

Authors:  D H Siegel; J McKenzie; I J Frieden; K A Rauen
Journal:  Br J Dermatol       Date:  2011-01-28       Impact factor: 9.302

7.  Neurological complications of cardio-facio-cutaneous syndrome.

Authors:  Grace Yoon; Jodine Rosenberg; Susan Blaser; Katherine A Rauen
Journal:  Dev Med Child Neurol       Date:  2007-12       Impact factor: 5.449

8.  Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis.

Authors:  Karen W Gripp; Dina J Zand; Laurie Demmer; Carol E Anderson; William B Dobyns; Elaine H Zackai; Elizabeth Denenberg; Kim Jenny; Deborah L Stabley; Katia Sol-Church
Journal:  Am J Med Genet A       Date:  2013-08-05       Impact factor: 2.802

9.  Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cells.

Authors:  Emilia Galperin; Lina Abdelmoti; Alexander Sorkin
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

10.  Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.

Authors:  Viviana Cordeddu; Elia Di Schiavi; Len A Pennacchio; Avi Ma'ayan; Anna Sarkozy; Valentina Fodale; Serena Cecchetti; Alessio Cardinale; Joel Martin; Wendy Schackwitz; Anna Lipzen; Giuseppe Zampino; Laura Mazzanti; Maria C Digilio; Simone Martinelli; Elisabetta Flex; Francesca Lepri; Deborah Bartholdi; Kerstin Kutsche; Giovanni B Ferrero; Cecilia Anichini; Angelo Selicorni; Cesare Rossi; Romano Tenconi; Martin Zenker; Daniela Merlo; Bruno Dallapiccola; Ravi Iyengar; Paolo Bazzicalupo; Bruce D Gelb; Marco Tartaglia
Journal:  Nat Genet       Date:  2009-08-16       Impact factor: 38.330

View more
  17 in total

1.  Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.

Authors:  Myoungkun Jeoung; Eun Ryoung Jang; Jinpeng Liu; Chi Wang; Eric C Rouchka; Xiaohong Li; Emilia Galperin
Journal:  Cell Signal       Date:  2016-02-11       Impact factor: 4.315

Review 2.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

3.  Spatial control of Shoc2-scaffold-mediated ERK1/2 signaling requires remodeling activity of the ATPase PSMC5.

Authors:  Eun Ryoung Jang; HyeIn Jang; Ping Shi; Gabriel Popa; Myoungkun Jeoung; Emilia Galperin
Journal:  J Cell Sci       Date:  2015-10-30       Impact factor: 5.285

4.  Hematopoietic and neural crest defects in zebrafish shoc2 mutants: a novel vertebrate model for Noonan-like syndrome.

Authors:  HyeIn Jang; Erin Oakley; Marie Forbes-Osborne; Melissa V Kesler; Rebecca Norcross; Ann C Morris; Emilia Galperin
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

5.  The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair.

Authors:  Patricia Wilson; Lina Abdelmoti; Rebecca Norcross; Eun Ryoung Jang; Malathy Palayam; Emilia Galperin
Journal:  J Cell Sci       Date:  2021-11-05       Impact factor: 5.285

6.  Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.

Authors:  Jason J Kwon; Behnoush Hajian; Yuemin Bian; Lucy C Young; Alvaro J Amor; James R Fuller; Cara V Fraley; Abbey M Sykes; Jonathan So; Joshua Pan; Laura Baker; Sun Joo Lee; Douglas B Wheeler; David L Mayhew; Nicole S Persky; Xiaoping Yang; David E Root; Anthony M Barsotti; Andrew W Stamford; Charles K Perry; Alex Burgin; Frank McCormick; Christopher T Lemke; William C Hahn; Andrew J Aguirre
Journal:  Nature       Date:  2022-07-13       Impact factor: 69.504

7.  Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.

Authors:  Daniel A Bonsor; Patrick Alexander; Kelly Snead; Nicole Hartig; Matthew Drew; Simon Messing; Lorenzo I Finci; Dwight V Nissley; Frank McCormick; Dominic Esposito; Pablo Rodriguez-Viciana; Andrew G Stephen; Dhirendra K Simanshu
Journal:  Nat Struct Mol Biol       Date:  2022-09-29       Impact factor: 18.361

8.  SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis.

Authors:  Lucy C Young; Nicole Hartig; Isabel Boned Del Río; Sibel Sari; Benjamin Ringham-Terry; Joshua R Wainwright; Greg G Jones; Frank McCormick; Pablo Rodriguez-Viciana
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

9.  Single-domain antibodies for functional targeting of the signaling scaffold Shoc2.

Authors:  HyeIn Jang; Patricia G Wilson; Mary Sau; Udeep Chawla; David W Rodgers; Emilia Galperin
Journal:  Mol Immunol       Date:  2019-12-20       Impact factor: 4.407

10.  The function of Shoc2: A scaffold and beyond.

Authors:  Eun Ryoung Jang; Emilia Galperin
Journal:  Commun Integr Biol       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.